Superseded public profile

Not FDA-approved↗Safety records↗

Superseded · version 2: GHK-Cu↗↗

Related names recorded in this version: Copper tripeptide-1, GHK copper↗

A copper-binding peptide named in FDA's list of bulk substances under evaluation for non-injectable compounding.↗↗

This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.
Update · July 29, 2026

We added FDA substance-identity aliases to improve search matching. The cited compounding-list status did not change. 2

What this version reported

FDA lists GHK-Cu, except injectable routes, in Category 1 for bulk substances under evaluation. That listing does not establish FDA approval, safety, or effectiveness.↗

Organizations named in cited records:
  • U.S. Food and Drug Administration↗

Sources for this version

  1. 1
    503A bulk drug substances under evaluation · GHK-Cu except injectable routes · updated May 14, 2026 ↗

    U.S. Food and Drug Administration · Official source · Source checked July 22, 2026

  2. 2
    Copper tripeptide-1 substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked July 29, 2026